Cleveland Clinic spinout secures $1.7M in seed investments to advance vascular navigation system

Centerline Biomedical, a Cleveland Clinic spinout founded in November 2014, has raised $1.7 million in seed capital to continue developing and testing its surgical navigation system.

Advertisement

Centerline’s vascular navigation system aims to greatly reduce radiation exposure to patients and caregivers and make surgical procedures safer, more accurate and cost-effective.

“The opportunity to positively impact a growing number of patients and providers alike is significant,” Matthew Eagleton, MD, chair of the medical advisory board for Centerline, said in a statement. “Centerline’s platform technology solves an immediate need and has the ability to transform many vascular and non-vascular procedures by reducing radiation, improving outcomes and saving costs.”

More articles on health IT:
Xerox rebrands health strategy; aims to compete with HP, IBM
Medtronic acquires Medina Medical for $150M
Western Connecticut Health Network to implement Cerner solution suite

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.